Indoximod-based chemo-immunotherapy for pediatric brain tumors: A first-in-children phase I trial
TS Johnson, TJ MacDonald, R Pacholczyk… - Neuro …, 2024 - academic.oup.com
Background Recurrent brain tumors are the leading cause of cancer death in children.
Indoleamine 2, 3-dioxygenase (IDO) is a targetable metabolic checkpoint that, in preclinical …
Indoleamine 2, 3-dioxygenase (IDO) is a targetable metabolic checkpoint that, in preclinical …
Real-life experience with a “modified-MEMMAT” regimen for relapsed medulloblastoma
A Cacchione, G Del Baldo, F D'Antonio, V Di Ruscio… - 2024 - researchsquare.com
Real-life experience with a “modified-MEMMAT” regimen for relapsed medulloblastoma Page 1
Page 1/22 Real-life experience with a “modi ed-MEMMAT” regimen for relapsed …
Page 1/22 Real-life experience with a “modi ed-MEMMAT” regimen for relapsed …